MedPath

FRAXIPARINE FORTE

FRAXIPARINE FORTE

Dormant
DIN Number

02240114

Drug Class

Human

Market Date

Jun 22, 1999

Company
HC

Aspen Pharmacare Canada Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02240114
AIG Number0131662002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB06 NADROPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous ,  Intravenous
AHFS Classification20:12.04.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

NADROPARIN CALCIUMActive
Strength: 19000 UNIT / ML
Monograph: NADROPARIN CALCIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.